Nicorandil for heart health in rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study tests a medicine called nicorandil, which is normally used for chest pain, to see if it can lower the risk of heart disease in people with rheumatoid arthritis. If you have RA and are already on standard treatment, this may help protect your heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 70 years old.
- You must have rheumatoid arthritis confirmed by a doctor.
- You must have been on a standard RA medicine (like methotrexate) for at least 3 months.
- You cannot be taking biologic RA medicines (like Humira or Enbrel).
- You cannot be on cholesterol-lowering drugs (like statins).
- You cannot have diabetes, kidney or liver problems, or a history of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a heart medication called nicorandil can help reduce arthritis symptoms when added to your current treatment. It is for people with moderate to severe rheumatoid arthritis who have been stable on their current treatments.
This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.
This study tests whether niacin, a common vitamin, can help reduce inflammation and improve disease activity in people with rheumatoid arthritis who also have high cholesterol. It may offer an additional treatment option without the need for biologics.
This study looks at whether calcium in the heart arteries and a blood test (troponin) can help predict heart disease risk in people with rheumatoid arthritis. It may help doctors better prevent heart attacks and strokes.
This study looks at people with very early rheumatoid arthritis to see if a simple blood test and an ultrasound of the neck can show early signs of heart artery damage. The goal is to catch heart disease risk sooner in RA patients.
This study tests whether using ultrasound to look at arteries in the neck can help prevent heart attacks and strokes in people with inflammatory joint diseases like rheumatoid arthritis or lupus. Researchers will use the results to guide treatment decisions.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.